We note that the Sight Sciences, Inc. (NASDAQ:SGHT) Co-Founder, Paul Badawi, recently sold US$76k worth of stock for US$5.99 per share. However we note that the sale only shrunk their holding by 0.2%.
Sight Sciences Insider Transactions Over The Last Year
Over the last year, we can see that the biggest insider purchase was by Independent Chairman Staffan Encrantz for US$1.8m worth of shares, at about US$3.46 per share. We do like to see buying, but this purchase was made at well below the current price of US$5.81. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
Staffan Encrantz bought 985.12k shares over the last 12 months at an average price of US$3.04. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
Sight Sciences is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
Insider Ownership
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Sight Sciences insiders own about US$61m worth of shares. That equates to 21% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
So What Do The Sight Sciences Insider Transactions Indicate?
Insiders sold stock recently, but they haven't been buying. In contrast, they appear keener if you look at the last twelve months. It's good to see insiders are shareholders. So the recent selling doesn't worry us too much. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Sight Sciences. Every company has risks, and we've spotted 4 warning signs for Sight Sciences you should know about.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
